A Phase 1 Study of AB521 Monotherapy and Combination Therapies in Renal Cell Carcinoma and Other Solid Tumors

Research Site, Birmingham, Alabama, United States

Research Site, San Diego, California, United States

Research Site, Santa Monica, California, United States

Research Site, Miami, Florida, United States

Research Site, Atlanta, Georgia, United States

Research Site, Louisville, Kentucky, United States

Research Site, New Orleans, Louisiana, United States

Research Site, Baltimore, Maryland, United States

Research Site, Boston, Massachusetts, United States

Research Site, Detroit, Michigan, United States

Research Site, Detroit, Michigan, United States

Research Site, Omaha, Nebraska, United States

Research Site, New York, New York, United States

Research Site, New York, New York, United States

Research Site, Cleveland, Ohio, United States

Research Site, Cleveland, Ohio, United States

Research Site, Pittsburgh, Pennsylvania, United States

Research Site, Nashville, Tennessee, United States

Research Site, Nashville, Tennessee, United States

Research Site, San Antonio, Texas, United States

Research Site, Camperdown, Australia

Research Site, Melbourne, Australia

Research Site, Sydney, Australia

Research Site, Seoul, South Korea

Research Site, Barcelona, Spain